sei Biotherapeutics (SNSE) has changed its corporate name to Faeth Therapeutics.
The companyâs common stock is expected to begin trading on the Nasdaq Capital Market under the new ticker symbol âFTHâ on June 16, 2026. – The company has launched a new corporate website at – SNSE +19.15% to $15.49